{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:15:51Z","timestamp":1767374151116,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,9,10]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>This case presents CT-guided percutaneous cryoablation as a treatment option in a patient with oligometastatic breast cancer who previously had received standard-of-care treatment for metastatic breast cancer. Before cryoablation, the patient received two systemic lines of therapy, several surgeries and radiotherapy for oligometastatic disease. The cryoablation was performed in a single 7 mm subpleural oligometastatic lesion 42 months after diagnosis of metastatic breast cancer. It was performed without complications, and the patient experienced no complaints or discomfort after the procedure. A 3-month, 6-month, 9-month and 12-month follow-up fluorodeoxyglucose-positron emission tomography\/CT scans showed no sign of disease progression.<\/jats:p>","DOI":"10.1136\/bcr-2023-256256","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T20:55:22Z","timestamp":1697748922000},"page":"e256256","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Image-guided percutaneous cryoablation of a solitary subpleural lung metastasis from breast cancer"],"prefix":"10.1136","volume":"16","author":[{"given":"John","family":"Valtersson","sequence":"first","affiliation":[{"name":"UNIFY - Research and Innovation Unit of Radiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Vogsen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Odense University Hospital, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Graumann","sequence":"additional","affiliation":[{"name":"Department of Radiology, Odense University Hospital, Odense, Denmark"},{"name":"UNIFY - Research and Innovation Unit of Radiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5718-3635","authenticated-orcid":false,"given":"Pia Iben","family":"Pietersen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Odense University Hospital, Odense, Denmark"},{"name":"UNIFY - Research and Innovation Unit of Radiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"2025082723361348000_16.10.e256256.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025082723361348000_16.10.e256256.2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2025082723361348000_16.10.e256256.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.19323"},{"key":"2025082723361348000_16.10.e256256.4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ijc.33693","article-title":"Oligometastatic breast cancer: are we there yet?","volume":"149","author":"AlSendi","year":"2021","journal-title":"Int J Cancer"},{"key":"2025082723361348000_16.10.e256256.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.04.003"},{"key":"2025082723361348000_16.10.e256256.6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/RLU.0000000000003502","article-title":"Impact of 18F-FDG PET, PET\/CT, and PET\/MRI on staging and management as an initial staging modality in breast cancer: a systematic review and meta-analysis","volume":"46","author":"Han","year":"2021","journal-title":"Clin Nucl Med"},{"key":"2025082723361348000_16.10.e256256.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.5185"},{"key":"2025082723361348000_16.10.e256256.8","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-021-00889-2","article-title":"Treatment strategies for oligometastatic breast cancer","volume":"22","author":"Nesbit","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"2025082723361348000_16.10.e256256.9","doi-asserted-by":"publisher","DOI":"10.1080\/21681805.2020.1794954"},{"key":"2025082723361348000_16.10.e256256.10","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1007\/s00261-021-03082-z","article-title":"Cryoablation of renal tumors: long-term follow-up from a multicenter experience","volume":"46","author":"Stacul","year":"2021","journal-title":"Abdom Radiol"},{"key":"2025082723361348000_16.10.e256256.11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1055\/a-0598-5134","article-title":"Current technique and application of percutaneous cryotherapy","volume":"190","author":"Mahnken","year":"2018","journal-title":"Rofo"},{"key":"2025082723361348000_16.10.e256256.12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jvir.2020.02.016","article-title":"Predictors of progression-free survival and local tumor control after percutaneous thermal ablation of oligometastatic breast cancer: retrospective study","volume":"31","author":"Ridouani","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"2025082723361348000_16.10.e256256.13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227129","article-title":"Percutaneous cryoablation of a solitary, soft-tissue metastasis from renal cell carcinoma: a new local minimal invasive curative treatment","volume":"12","author":"Junker","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2025082723361348000_16.10.e256256.14","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225841","article-title":"Cryoablation: a potential treatment option for renal metastasis from lung cancer","volume":"2018","author":"Degn","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2025082723361348000_16.10.e256256.15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0039-1697002","article-title":"Cryoablation of lung metastases: review of recent literature and ablation technique","volume":"36","author":"Eiken","year":"2019","journal-title":"Semin Intervent Radiol"},{"key":"2025082723361348000_16.10.e256256.16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0039-1693981","article-title":"Lung ablation: indications and techniques","volume":"36","author":"Tafti","year":"2019","journal-title":"Semin Intervent Radiol"},{"key":"2025082723361348000_16.10.e256256.17","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2019.1647358"},{"key":"2025082723361348000_16.10.e256256.18","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/521691","article-title":"Cryoablation of early-stage primary lung cancer","volume":"2014","author":"Inoue","year":"2014","journal-title":"Biomed Res Int"},{"key":"2025082723361348000_16.10.e256256.19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2020.02.022","article-title":"Multicenter study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE)","volume":"15","author":"Callstrom","year":"2020","journal-title":"J Thorac Oncol"},{"key":"2025082723361348000_16.10.e256256.20","doi-asserted-by":"publisher","DOI":"10.1080\/02841860600908954"},{"key":"2025082723361348000_16.10.e256256.21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/0284186X.2018.1521986","article-title":"Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy","volume":"58","author":"Sharma","year":"2019","journal-title":"Acta Oncol"},{"key":"2025082723361348000_16.10.e256256.22","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-019-0727-5","article-title":"Cryoablation and immunotherapy: an overview of evidence on its synergy","volume":"10","author":"Aarts","year":"2019","journal-title":"Insights Imaging"},{"key":"2025082723361348000_16.10.e256256.23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cryobiol.2013.04.004","article-title":"Cryotherapy protocols for metastatic breast cancer after failure of radical surgery","volume":"67","author":"Niu","year":"2013","journal-title":"Cryobiology"},{"key":"2025082723361348000_16.10.e256256.24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2022.40.16_suppl.1007","article-title":"NRG-BR002: a phase IIR\/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and\/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557)","volume":"40","author":"Chmura","year":"2022","journal-title":"JCO"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-256256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:36:25Z","timestamp":1756362985000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-256256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,19]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bcr-2023-256256"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-256256","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}